AI-Driven Genomic Sequencing: Revolutionizing Personalized Medicine Through Predictive Analytics

Abstract

Smart genomic sequencing enhances customised treatment. Changing illness risk assessment and treatment customisation. NGS speeds genomic data growth. This creates plenty of data, but its size and complexity make analysis challenging. Genetic knowledge changes with ML and DL. These reveal facts ordinary methods cannot. This research studies how AI models may enhance genetic sequence analysis for illness risk prediction and personalised treatment. 

AI-driven genomic sequencing uses strong algorithms to detect patterns in enormous datasets. Massive genomic sequences determine illness risk, progression, and therapy success. Supervised learning algorithms may relate genetic differences to cancer, heart disease, and rare genetic diseases. Genomic data may help AI systems discover genetic predispositions. Doctors may forecast illness and design preventative or early therapies using DNA. 

AI can find biomarkers for customised medicine. Traditional analytical approaches cannot identify and verify genetic, epigenetic, and proteomic biomarkers. AI systems can. To better comprehend patients, AI may incorporate genomic, transcriptomic, proteomic, and metabolomic data. Merging biological data from several sources may help AI models comprehend patient health. More accurate diagnosis and treatment. 

Drug development may benefit from genome sequencing and AI. Genetic and patient-specific clinical data may assist AI models anticipate pharmaceutical effects. This helps doctors identify the best medicine and reduce side effects. AI must inform cancer genome sequencing and therapy selection. AI can accelerate medication development and improve patient outcomes by predicting targeted therapy effectiveness, finding new drug candidates, and suggesting new drug combinations. 

AI simplifies genomic annotation. Genomic medicine has struggled to annotate genetic variations, especially those of questionable significance. Massive datasets and novel patterns may help AI grasp genetic variation and annotations. Clinicians may utilise genomic data to make smart genetic choices. 

Genetic sequencing AI is sophisticated yet limited. Data quality and representativeness are still important since biassed or inadequate training data may lead to erroneous predictions and aggravate health inequalities. Genetic data privacy and security, particularly across geographies, must be addressed to use AI. Many advanced AI systems are "black boxes," making predictions confusing. Clinical adoption of AI-generated solutions demands extensive decision-making explanations, making implementation harder without transparency. 

Despite these problems, AI-powered genome sequencing seems promising. Explainable AI (XAI) may solve these issues by clarifying model choices. AI and genetic data from all races and ethnicities may improve models and provide predictions for all races and locations. As computers and algorithms improve, genetic medicine will need AI models for precision treatment. 

AI may affect genetic sequencing and therapy. AI models may change healthcare practice by improving sickness risk assessments, finding new biomarkers, and simplifying personalised treatment regimens. These technologies may enhance patient outcomes and enable healthcare systems address complicated illnesses and diverse populations. AI-driven genome sequencing will personalise, enhance, and equalise precision medicine.